Boston Scientific exercises option to buy remaining shares of Millipede

Image: The transaction is expected to expand Boston Scientific’s structural heart portfolio to include transcatheter mitral annuloplasty repair system. Photo: courtesy of Boston Scientific Corporation.



  • Boston Scientific